Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practiceG Lelli, S Cataldo, I Carandina, et al.
British Journal of Cancer|July 1, 2015
Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteinsA Khadjavi, F Mannu, P Destefanis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcomaS Stacchiotti, M A Pantaleo, A Astolfi, et al.
ESMO Open|October 25, 2023
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancerM Nannini, A Repaci, M C Nigro, et al.
Frontiers in Immunology|March 19, 2026
Integrative genomic and immune landscape analysis of intimal sarcomas for emerging therapeutic targets and immunotherapy strategiesLivia Gozzellino, Alice Costa, Margherita Nannini, et al.
Oncoimmunology|August 21, 2019
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors responseMaria A Pantaleo, Giuseppe Tarantino, Claudio Agostinelli, et al.
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
Molecular Cancer Research : MCR|June 4, 2016
Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q LossSilvia Stacchiotti, Annalisa Astolfi, Alessandro Gronchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)Silvia Stacchiotti, Maria A Pantaleo, Tiziana Negri, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Pageof 12